These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18810454)

  • 1. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.
    Ba-Ssalamah A; Uffmann M; Saini S; Bastati N; Herold C; Schima W
    Eur Radiol; 2009 Feb; 19(2):342-57. PubMed ID: 18810454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [VIBE with parallel acquisition technique - a novel approach to dynamic contrast-enhanced MR imaging of the liver].
    Dobritz M; Radkow T; Nittka M; Bautz W; Fellner FA
    Rofo; 2002 Jun; 174(6):738-41. PubMed ID: 12063604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement.
    Semelka RC; Martin DR; Balci C; Lance T
    J Magn Reson Imaging; 2001 Mar; 13(3):397-401. PubMed ID: 11241813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
    Ba-Ssalamah A; Happel B; Kettenbach J; Dirisamer A; Wrba F; Längle F; Schima W
    Radiologe; 2004 Dec; 44(12):1170-84. PubMed ID: 15551031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media].
    Bartolotta TV; Midiri M; Galia M; Carcione A; De Maria M; Lagalla R
    Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
    Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
    Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging.
    Takahama K; Amano Y; Hayashi H; Ishihara M; Kumazaki T
    Abdom Imaging; 2003; 28(4):525-30. PubMed ID: 14580096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast agents used in MR imaging of the liver.
    Karabulut N; Elmas N
    Diagn Interv Radiol; 2006 Mar; 12(1):22-30. PubMed ID: 16538580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
    Grimm J; Müller-Hülsbeck S; Blume J; Biederer J; Heller M
    Rofo; 2001 Mar; 173(3):266-72. PubMed ID: 11293872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ins and outs of liver imaging.
    O'Neill EK; Cogley JR; Miller FH
    Clin Liver Dis; 2015 Feb; 19(1):99-121. PubMed ID: 25454299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging of liver malignancies.
    Ba-Ssalamah A; Fakhrai N; Matzek WK; Herneth AM; Stadler A; Bastati N; Herold CJ; Schima W
    Top Magn Reson Imaging; 2007 Dec; 18(6):445-55. PubMed ID: 18303402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
    Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
    AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging of benign focal liver lesions.
    Ba-Ssalamah A; Baroud S; Bastati N; Qayyum A
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):403-19, ix. PubMed ID: 21094447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging in the evaluation of hepatic metastases.
    Imam K; Bluemke DA
    Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):741-56. PubMed ID: 11149677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of liver lesions.
    Bonder A; Afdhal N
    Clin Liver Dis; 2012 May; 16(2):271-83. PubMed ID: 22541698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
    Fowler KJ; Brown JJ; Narra VR
    Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.